Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01017523 · ClinicalTrials.gov registry record · Phase 3
Diabetes Support Project: Couples Intervention
A Phase 3 study of Type 2 Diabetes, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- Phase 3
- Development phase
- 268
- Enrollment target
- 2
- Study locations
NCT01017523: Completed Phase 3 study of Type 2 Diabetes, sponsored by State University of New York - Upstate Medical University.
NCT01017523 is a Phase 3 study of Type 2 Diabetes that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 268 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01017523, a Phase 3 study of Type 2 Diabetes, has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 268 participants
- Enrollment target
- 2
- Study locations
Study Summary
Research has shown that diabetes affects both the patient and family, and that support from family and partners helps diabetes patients manage their illness better. However, diabetes programs rarely involve the partner. The purpose of this study is to test an intervention that helps partners and patients who have type 2 diabetes better support each other. The intervention will be delivered over the telephone to reach more people. Our hypothesis is that an intervention that targets the couple has a greater effect on health and well-being of patients than one that targets the individual patient alone.
Conditions Studied
Interventions
- BEHAVIORAL Telephone support and behavior change
- OTHER Diabetes self-management education
Study Locations (2)
California
- University of California, San Francisco - San Francisco
New York
- SUNY Upstate Medical University, Dept. of Psychiatry - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 3 |
What the finished NCT01017523 record still lists
NCT01017523 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Telephone support and behavior change is the first listed.
NCT01017523 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT01017523 about?
NCT01017523 is a clinical study titled "Diabetes Support Project: Couples Intervention". Research has shown that diabetes affects both the patient and family, and that support from family and partners helps diabetes patients manage their illness better. However, diabetes programs rarely involve the partner. The purpose of this study is to test an intervention that helps partners and pat...
What is the current status of trial NCT01017523?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 268 participants. The study started on 2010-01. Estimated completion is 2015-01.
What conditions does trial NCT01017523 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT01017523?
The interventions under investigation include: Telephone support and behavior change (BEHAVIORAL), Diabetes self-management education (OTHER).
Who is sponsoring clinical trial NCT01017523?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01017523 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01017523's enrollment target sits among peer trials
268 78th of 327 higher than 250 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
RECRUITING · Phase 3
-
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RECRUITING · Phase 3
-
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
ACTIVE NOT RECRUITING · Phase 3
-
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
ACTIVE NOT RECRUITING · Phase 3
-
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia